Autori: Smith Jeffrey T
| Naslov | ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial. (Meeting Abstract) |
| Autori | Schuster Michael W Rigas James R Orlov Sergey V Milovanovic Branislav M Prabhash Kumar Smith Jeffrey T |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2010), vol. 28 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial. (Meeting Abstract) |
| Autori | Rigas James R Schuster Michael W Orlov Sergey V Milovanovic Branislav M Prabhash Kumar Smith Jeffrey T |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2010), vol. 28 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Inhibition of Interleukin-6 (IL-6) Reverses Anemia In Patients with Advanced Non Small Cell Lung Cancer (NSCLC): Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial (Meeting Abstract) |
| Autori | Schuster Michael W Rigas James R Orlov Sergey V Milovanovic Branislav M Prabhash Kumar Smith Jeffrey T |
| Info | BLOOD, (2010), vol. 116 br. 21, str. 281-281 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
